Evidence map›Paper›PMID 34162642›Full record

Observational studyBMJ open2021

Cohort profile: follow-up of a Berlin Aging Study II (BASE-II) subsample as part of the GendAge study.

Ilja Demuth, Verena Banszerus, Johanna Drewelies, Sandra Düzel, Ute Seeland, Dominik Spira, Esther Tse, Julian Braun, Elisabeth Steinhagen-Thiessen, Lars Bertram and 5 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Blood-based multivariate methylation risk score for cognitive impairment and dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 6 countries.

Ilja DemuthDepartment of Endocrinology and Metabolic Diseases (including Division of Lipid Metabolism), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany ilja.demuth@charite.de.ORCID 0000-0002-4340-2523
Verena BanszerusDepartment of Endocrinology and Metabolic Diseases (including Division of Lipid Metabolism), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
Johanna DreweliesDepartment of Psychology, Humboldt University of Berlin, Berlin, Berlin, Germany.
Sandra DüzelCenter for Lifespan Psychology, Max-Planck-Institute for Human Development, Berlin, Germany.
Ute SeelandCharité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Institute of Social Medicine, Epidemiology and Health Economics, Berlin, Germany.
Dominik SpiraDepartment of Endocrinology and Metabolic Diseases (including Division of Lipid Metabolism), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
Esther TseBerlin Institute for Gender in Medicine, Charite Universitatsmedizin Berlin, Berlin, Germany.
Julian BraunSi-M / "Der Simulierte Mensch" a science framework of Technische, Universitat Berlin andCharité - Universitatsmedizin Berlin, Berlin, Germany.
Elisabeth Steinhagen-ThiessenDepartment of Endocrinology and Metabolic Diseases (including Division of Lipid Metabolism), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
Lars BertramLübeck Interdisciplinary Platform for Genome Analytics, University of Lübeck, Lübeck, Germany.
Andreas ThielSi-M / "Der Simulierte Mensch" a science framework of Technische, Universitat Berlin andCharité - Universitatsmedizin Berlin, Berlin, Germany.
Ulman LindenbergerCenter for Lifespan Psychology, Max-Planck-Institute for Human Development, Berlin, Germany.
Vera Regitz-ZagrosekDZHK (German Centre for Cardiovascular Research), Partner site Berlin, Berlin, Germany.
Denis GerstorfDepartment of Psychology, Humboldt University of Berlin, Berlin, Berlin, Germany.
Additional BASE-II/GendAge investigators
Humboldt-Universität zu Berlin · DEOrthopädische Universitätsklinik · DEGender Studies · CZMax Planck Institute for Human Development · DEProstate Cancer Research · GBUniversity of Oslo · NOUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe study 'Sex- and gender-sensitive prevention of cardiovascular and metabolic disease in older adults in Germany', the GendAge study, focuses on major risk factors for cardiovascular and metabolic diseases and on the development of major outcomes from intermediate phenotypes in the context of sex and gender differences. It is based on a follow-up examination of a subsample (older group) of the Berlin Aging Study II (BASE-II).

participantsThe GendAge study assessments took place between 22 June 2018 and 10 March 2020. A total of 1100 participants (older BASE-II subsample, aged ≥65 years) with baseline data assessed at least by one of the BASE-II partner sites were investigated in the follow-up. These participants had a mean age of 75.6 years (SD ±3.8), with a mean follow-up at 7.4 years (SD ±1.5). FINDINGS TO DATE: Data from different domains such as internal medicine, geriatrics, immunology and psychology were collected, with a focus on cardiometabolic diseases and in the context of sex and gender differences. Diabetes mellitus type 2 was reported by 15.6% and 8.6% of men and women, respectively. In contrast, this disease was diagnosed in 20.7% of men and 13.3% of women, indicating that a substantial proportion of almost 30% was unaware of the disease. Echocardiography revealed that left ventricular ejection fraction was higher in women than in men, in agreement with previous reports. FUTURE PLANS: A gender questionnaire assessing sociocultural aspects implemented as part of the follow-up described here will allow to calculate a gender score and its evaluation based on the newly collected data. At the same time, the other BASE-II research foci established over the past 10 years will be continued and strengthened by the BASE-II transition into a longitudinal study with follow-up data on the older subsample. TRIAL REGISTRATION NUMBER: DRKS00016157.

Indexed as

AgingVentricular Function, LeftAgedBerlinFemaleFollow-Up StudiesGermanyHumansLongitudinal StudiesMaleRisk FactorsStroke Volumegeneral medicine (see Internal Medicine)geriatric medicinepublic healthvascular medicine

Identifiers

PMID34162642
PMCPMC8230995
OpenAlexW3175465443

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.